Acrivon Therapeutics maintains Outperform rating, $21 target May 15, 2024 by True Academy Comments are off Posted in:Stock Market & Investment NewsTagged with:Buy Sell ShareFTSEKLCIMalaysiaPelaburanSahamShare Trading See more Prev:Barings Global Short Duration High Yield Fund Announces May 2024 Monthly Distribution of $0.1056 per Share Back: All Posts Next:On Holding AG stock target raised on strong sales